210 related articles for article (PubMed ID: 18505833)
1. Loss of resistin ameliorates hyperlipidemia and hepatic steatosis in leptin-deficient mice.
Singhal NS; Patel RT; Qi Y; Lee YS; Ahima RS
Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E331-8. PubMed ID: 18505833
[TBL] [Abstract][Full Text] [Related]
2. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
3. Pollock oil supplementation modulates hyperlipidemia and ameliorates hepatic steatosis in mice fed a high-fat diet.
Yang ZH; Miyahara H; Takeo J; Hatanaka A; Katayama M
Lipids Health Dis; 2011 Oct; 10():189. PubMed ID: 22027268
[TBL] [Abstract][Full Text] [Related]
4. Beta-aminoisobutyric acid prevents diet-induced obesity in mice with partial leptin deficiency.
Begriche K; Massart J; Abbey-Toby A; Igoudjil A; Lettéron P; Fromenty B
Obesity (Silver Spring); 2008 Sep; 16(9):2053-67. PubMed ID: 19186330
[TBL] [Abstract][Full Text] [Related]
5. Partial leptin deficiency favors diet-induced obesity and related metabolic disorders in mice.
Begriche K; Lettéron P; Abbey-Toby A; Vadrot N; Robin MA; Bado A; Pessayre D; Fromenty B
Am J Physiol Endocrinol Metab; 2008 May; 294(5):E939-51. PubMed ID: 18349116
[TBL] [Abstract][Full Text] [Related]
6. Loss of resistin improves glucose homeostasis in leptin deficiency.
Qi Y; Nie Z; Lee YS; Singhal NS; Scherer PE; Lazar MA; Ahima RS
Diabetes; 2006 Nov; 55(11):3083-90. PubMed ID: 17065346
[TBL] [Abstract][Full Text] [Related]
7. Deficiency of carboxylesterase 1/esterase-x results in obesity, hepatic steatosis, and hyperlipidemia.
Quiroga AD; Li L; Trötzmüller M; Nelson R; Proctor SD; Köfeler H; Lehner R
Hepatology; 2012 Dec; 56(6):2188-98. PubMed ID: 22806626
[TBL] [Abstract][Full Text] [Related]
8. Diet-genotype interactions in the early development of obesity and insulin resistance in mice with a genetic deficiency in tumor necrosis factor-alpha.
Bouter B; Geary N; Langhans W; Asarian L
Metabolism; 2010 Jul; 59(7):1065-73. PubMed ID: 20045154
[TBL] [Abstract][Full Text] [Related]
9. Adiponectin is stimulated by adrenalectomy in ob/ob mice and is highly correlated with resistin mRNA.
Makimura H; Mizuno TM; Bergen H; Mobbs CV
Am J Physiol Endocrinol Metab; 2002 Dec; 283(6):E1266-71. PubMed ID: 12388167
[TBL] [Abstract][Full Text] [Related]
10. GLP-1 Elicits an Intrinsic Gut-Liver Metabolic Signal to Ameliorate Diet-Induced VLDL Overproduction and Insulin Resistance.
Khound R; Taher J; Baker C; Adeli K; Su Q
Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2252-2259. PubMed ID: 29074588
[TBL] [Abstract][Full Text] [Related]
11. Partial leptin deficiency confers resistance to diet-induced obesity in mice.
Zhao S; Li N; Zhu Y; Straub L; Zhang Z; Wang MY; Zhu Q; Kusminski CM; Elmquist JK; Scherer PE
Mol Metab; 2020 Jul; 37():100995. PubMed ID: 32289482
[TBL] [Abstract][Full Text] [Related]
12. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
[TBL] [Abstract][Full Text] [Related]
13. Conjugated linoleic acid fails to worsen insulin resistance but induces hepatic steatosis in the presence of leptin in ob/ob mice.
Wendel AA; Purushotham A; Liu LF; Belury MA
J Lipid Res; 2008 Jan; 49(1):98-106. PubMed ID: 17906221
[TBL] [Abstract][Full Text] [Related]
14. Improvement of insulin sensitivity after peroxisome proliferator-activated receptor-alpha agonist treatment is accompanied by paradoxical increase of circulating resistin levels.
Haluzik MM; Lacinova Z; Dolinkova M; Haluzikova D; Housa D; Horinek A; Vernerova Z; Kumstyrova T; Haluzik M
Endocrinology; 2006 Sep; 147(9):4517-24. PubMed ID: 16740970
[TBL] [Abstract][Full Text] [Related]
15. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
[TBL] [Abstract][Full Text] [Related]
16. iPLA2β deficiency attenuates obesity and hepatic steatosis in ob/ob mice through hepatic fatty-acyl phospholipid remodeling.
Deng X; Wang J; Jiao L; Utaipan T; Tuma-Kellner S; Schmitz G; Liebisch G; Stremmel W; Chamulitrat W
Biochim Biophys Acta; 2016 May; 1861(5):449-61. PubMed ID: 26873633
[TBL] [Abstract][Full Text] [Related]
17. Repetitive orogastric gavage affects the phenotype of diet-induced obese mice.
de Meijer VE; Le HD; Meisel JA; Puder M
Physiol Behav; 2010 Jun; 100(4):387-93. PubMed ID: 20385157
[TBL] [Abstract][Full Text] [Related]
18. Changes in glycemia by leptin administration or high- fat feeding in rodent models of obesity/type 2 diabetes suggest a link between resistin expression and control of glucose homeostasis.
Asensio C; Cettour-Rose P; Theander-Carrillo C; Rohner-Jeanrenaud F; Muzzin P
Endocrinology; 2004 May; 145(5):2206-13. PubMed ID: 14962997
[TBL] [Abstract][Full Text] [Related]
19. Dietary and genetic evidence for enhancing glucose metabolism and reducing obesity by inhibiting klotho functions.
Ohnishi M; Kato S; Akiyoshi J; Atfi A; Razzaque MS
FASEB J; 2011 Jun; 25(6):2031-9. PubMed ID: 21382979
[TBL] [Abstract][Full Text] [Related]
20. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
Liu LF; Purushotham A; Wendel AA; Belury MA
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
